Sign In
to Vote &
Create Storyboards.
 

FDA approves Impavido to treat tropical disease leishmaniasis

Medical News Today - 21 Mar 2014 11:00
The U.S. Food and Drug Administration has approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis.Leishmaniasis is a disease caused by Leishmania, a parasite which is transmitted to humans through sand fly bites. The disease occurs primarily in people who live in the tropics and subtropics. Most U.S. patients acquire leishmaniasis overseas.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard